LOGIN  |  REGISTER
Recursion

Modivcare Announces Resignation of Stacy Saal from Board of Directors

October 27, 2023 | Last Trade: US$4.24 0.56 -11.67

DENVER / Oct 27, 2023 / Business Wire / Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Stacy Saal has stepped down from the Board of Directors in order to dedicate more time to her new professional endeavors.

“We are grateful for Stacy’s contributions to Modivcare and we wish her the best as she turns to her next chapter and pursues a number of exciting projects,” said Chris Shackelton, Chairman of Modivcare’s Board of Directors. “From her first day on the Board, Stacy was dedicated to driving value for shareholders. The experience, diligence, and intellect she brought to the Company made us better, and she will be missed.”

As a result of Ms. Saal’s resignation, the Board of Directors has decreased the size of the Board from ten to nine directors.

About Modivcare

Modivcare Inc. (Nasdaq: MODV) is a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions for public and private payors and their members. Our value-based solutions address the social determinants of health (SDoH), enable greater access to care, reduce costs, and improve outcomes. We are a leading provider of non-emergency medical transportation (NEMT), personal care and remote patient monitoring. To learn more about Modivcare, please visit www.modivcare.com.

Terns Pharmaceuticals

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page